Dexcom (DXCM) official guidance
Dexcom (DXCM) official earnings guidance and management outlook. Each figure management stated is shown with its revisions and the source quote.
See the full Filings Intelligence suiteDXCMDEXCOM INCFY2026 · ends 2026-12-31
5 metrics5 maintainedearnings call · 17h
2026-10-29 21:51:39 UTC32%maintained
We are increasing our non-GAAP operating profit margin guidance to approximately 24% and adjusted EBITDA margin guidance to approximately 32%.
DXCM · transcript · Q3 FY2026
2026-10-29 21:51:00 UTCOpen source
2026-10-29 20:04:50 UTC32%raised +0.8%
Adjusted EBITDA Margin of approximately 32%
DXCM · EX-99.1 · Q3 FY2026
2026-10-29 20:03:50 UTCOpen source
2026-07-31 04:00:47 UTC31.5% – 32%maintained
We are also increasing our non-GAAP operating profit margin guidance to a range of 23.5%-24% and adjusted EBITDA margin guidance to a range of 31.5%-32%.
DXCM · transcript · Q2 FY2026
2026-07-31 04:00:00 UTCOpen source
2026-07-30 20:04:08 UTC31.5% – 32%raised +1.6%
•Adjusted EBITDA Margin of approximately 31.5-32%
DXCM · EX-99.1 · Q2 FY2026
2026-07-30 20:03:41 UTCOpen source
2026-05-01 04:01:04 UTC31% – 31.5%maintained
For margins, we are reiterating our previous full year non-GAAP gross profit margin guidance of 63%-64% and increasing our non-GAAP operating profit margin guidance and Adjusted EBITDA margin guidance to 23%-23.5% and 31%-31.5% respectively.
DXCM · transcript · Q1 FY2026
2026-05-01 04:00:00 UTCOpen source
2026-04-30 20:03:09 UTC31% – 31.5%raised +2.5%
•Adjusted EBITDA Margin of approximately 31-31.5%
DXCM · EX-99.1 · Q1 FY2026
2026-04-30 20:02:43 UTCOpen source
2026-02-13 05:01:16 UTC30% – 31%maintained
From a margin perspective, we expect full-year non-GAAP gross profit margin to be in a range of 63%-64%, non-GAAP operating profit margin to be approximately 22%-23%, and adjusted EBITDA margin of approximately 30%-31%.
DXCM · transcript · Q4 FY2025
2026-02-13 05:00:00 UTCOpen source
2026-02-12 21:04:09 UTC30% – 31%new
•Adjusted EBITDA Margin of approximately 30-31%
DXCM · EX-99.1 · Q4 FY2025
2026-02-12 21:03:42 UTCOpen source
2026-10-29 21:51:39 UTC64%maintained
For margins, we are maintaining our full-year non-GAAP gross profit margin guidance at approximately 64%.
DXCM · transcript · Q3 FY2026
2026-10-29 21:51:00 UTCOpen source
2026-10-29 20:04:50 UTC64%maintained
Non-GAAP Gross Profit Margin of approximately 64%
DXCM · EX-99.1 · Q3 FY2026
2026-10-29 20:03:50 UTCOpen source
2026-07-31 04:00:47 UTC64%maintained
For margins, we are raising our full-year non-GAAP gross profit margin guidance to approximately 64%.
DXCM · transcript · Q2 FY2026
2026-07-31 04:00:00 UTCOpen source
2026-07-30 20:04:08 UTC64%raised +0.8%
•Non-GAAP Gross Profit Margin of approximately 64%
DXCM · EX-99.1 · Q2 FY2026
2026-07-30 20:03:41 UTCOpen source
2026-05-01 04:01:04 UTC63% – 64%maintained
For margins, we are reiterating our previous full year non-GAAP gross profit margin guidance of 63%-64% and increasing our non-GAAP operating profit margin guidance and Adjusted EBITDA margin guidance to 23%-23.5% and 31%-31.5% respectively.
DXCM · transcript · Q1 FY2026
2026-05-01 04:00:00 UTCOpen source
2026-04-30 20:03:09 UTC63% – 64%maintained
•Non-GAAP Gross Profit Margin of approximately 63-64%
DXCM · EX-99.1 · Q1 FY2026
2026-04-30 20:02:43 UTCOpen source
2026-02-13 05:01:16 UTC63% – 64%maintained
From a margin perspective, we expect full-year non-GAAP gross profit margin to be in a range of 63%-64%, non-GAAP operating profit margin to be approximately 22%-23%, and adjusted EBITDA margin of approximately 30%-31%.
DXCM · transcript · Q4 FY2025
2026-02-13 05:00:00 UTCOpen source
2026-02-12 21:04:09 UTC63% – 64%maintained
•Non-GAAP Gross Profit Margin of approximately 63-64%
DXCM · EX-99.1 · Q4 FY2025
2026-02-12 21:03:42 UTCOpen source
2026-01-12 12:31:17 UTC63% – 64%new
–Non-GAAP Gross Profit Margin of approximately 63 – 64%
DXCM · EX-99.1 · Q4 FY2025
2026-01-12 12:30:45 UTCOpen source
2026-10-29 21:51:39 UTC24%maintained
We are increasing our non-GAAP operating profit margin guidance to approximately 24% and adjusted EBITDA margin guidance to approximately 32%.
DXCM · transcript · Q3 FY2026
2026-10-29 21:51:00 UTCOpen source
2026-10-29 20:04:50 UTC24%raised +1.1%
Non-GAAP Operating Margin of approximately 24%
DXCM · EX-99.1 · Q3 FY2026
2026-10-29 20:03:50 UTCOpen source
2026-07-31 04:00:47 UTC23.5% – 24%maintained
We are also increasing our non-GAAP operating profit margin guidance to a range of 23.5%-24% and adjusted EBITDA margin guidance to a range of 31.5%-32%.
DXCM · transcript · Q2 FY2026
2026-07-31 04:00:00 UTCOpen source
2026-07-30 20:04:08 UTC23.5% – 24%raised +2.2%
•Non-GAAP Operating Margin of approximately 23.5-24%
DXCM · EX-99.1 · Q2 FY2026
2026-07-30 20:03:41 UTCOpen source
2026-05-01 04:01:04 UTC23% – 23.5%maintained
For margins, we are reiterating our previous full year non-GAAP gross profit margin guidance of 63%-64% and increasing our non-GAAP operating profit margin guidance and Adjusted EBITDA margin guidance to 23%-23.5% and 31%-31.5% respectively.
DXCM · transcript · Q1 FY2026
2026-05-01 04:00:00 UTCOpen source
2026-04-30 20:03:09 UTC23% – 23.5%raised +3.3%
•Non-GAAP Operating Margin of approximately 23-23.5%
DXCM · EX-99.1 · Q1 FY2026
2026-04-30 20:02:43 UTCOpen source
2026-02-13 05:01:16 UTC22% – 23%maintained
From a margin perspective, we expect full-year non-GAAP gross profit margin to be in a range of 63%-64%, non-GAAP operating profit margin to be approximately 22%-23%, and adjusted EBITDA margin of approximately 30%-31%.
DXCM · transcript · Q4 FY2025
2026-02-13 05:00:00 UTCOpen source
2026-02-12 21:04:09 UTC22% – 23%maintained
•Non-GAAP Operating Margin of approximately 22-23%
DXCM · EX-99.1 · Q4 FY2025
2026-02-12 21:03:42 UTCOpen source
2026-01-12 12:31:17 UTC22% – 23%new
–Non-GAAP Operating Margin of approximately 22 – 23%
DXCM · EX-99.1 · Q4 FY2025
2026-01-12 12:30:45 UTCOpen source
2026-10-29 21:51:39 UTC50%maintained
This leaves us on track to convert nearly 50% of our U.S. customer base to G7 15 Day by year-end.
DXCM · transcript · Q3 FY2026
2026-10-29 21:51:00 UTCOpen source
2026-07-31 04:00:47 UTC50%new
Based on this positive customer feedback, strong adoption trends, and growing interest across the market, we remain on track to convert nearly 50% of our U.S. customer base to the Dexcom G7 15-day system by year-end.
DXCM · transcript · Q2 FY2026
2026-07-31 04:00:00 UTCOpen source
2026-10-29 21:51:39 UTC$5.2B – $5.3Bmaintained11.5% – 12.6% vs FY2025
Turning to guidance, we are updating our revenue guidance to be in the range of $5.20 billion-$5.25 billion, representing growth of 12%-13% for the year.
DXCM · transcript · Q3 FY2026
2026-10-29 21:51:00 UTCOpen source
2026-10-29 20:04:50 UTC$5.2B – $5.3Braised +0.2%11.5% – 12.6% vs FY2025
Revenue of $5.20 - $5.25 billion (approximately 12-13% growth)
DXCM · EX-99.1 · Q3 FY2026
2026-10-29 20:03:50 UTCOpen source
2026-07-31 04:00:47 UTC$5.2B – $5.3Bmaintained11.1% – 12.6% vs FY2025
Turning to guidance, we are raising the midpoint of our guidance with an updated range of $5.18 billion-$5.25 billion, representing growth of 11%-13% for the year.
DXCM · transcript · Q2 FY2026
2026-07-31 04:00:00 UTCOpen source
2026-07-30 20:04:08 UTC$5.2B – $5.3Braised +0.2%11.1% – 12.6% vs FY2025
•Revenue of $5.18 - $5.25 billion (approximately 11-13% growth)
DXCM · EX-99.1 · Q2 FY2026
2026-07-30 20:03:41 UTCOpen source
2026-05-01 04:01:04 UTC$5.2B – $5.3Bmaintained10.7% – 12.6% vs FY2025
We are reaffirming our prior revenue guidance of $5.16 billion-$5.25 billion, representing growth of 11%-13% for the year.
DXCM · transcript · Q1 FY2026
2026-05-01 04:00:00 UTCOpen source
2026-04-30 20:03:09 UTC$5.2B – $5.3Bmaintained10.7% – 12.6% vs FY2025
•Revenue of $5.16 - $5.25 billion (approximately 11-13% growth)
DXCM · EX-99.1 · Q1 FY2026
2026-04-30 20:02:43 UTCOpen source
2026-02-13 05:01:16 UTC$5.2B – $5.3Bmaintained10.7% – 12.6% vs FY2025
As we stated last month, we anticipate total revenue to be in a range of $5.16 billion-$5.25 billion, representing growth of 11%-13% for the year.
DXCM · transcript · Q4 FY2025
2026-02-13 05:00:00 UTCOpen source
2026-02-12 21:04:09 UTC$5.2B – $5.3Bmaintained10.7% – 12.6% vs FY2025
•Revenue of $5.16 - $5.25 billion (approximately 11-13% growth)
DXCM · EX-99.1 · Q4 FY2025
2026-02-12 21:03:42 UTCOpen source
2026-01-12 12:31:17 UTC$5.2B – $5.3Bnew
For 2026, Dexcom currently anticipates total revenue of $5.16 - $5.25 billion, representing expected growth of approximately 11-13% over 2025.
DXCM · EX-99.1 · Q4 FY2025
2026-01-12 12:30:45 UTCOpen source
DXCMDEXCOM INCQ4 FY2026 · ends 2026-12-31
1 metric1 newearnings call · 17h
2026-10-29 21:51:39 UTC10%new
This also implies midpoint fourth quarter growth of 10%.
DXCM · transcript · Q3 FY2026
2026-10-29 21:51:00 UTCOpen source
DXCMDEXCOM INCFY2030+ · ends 2030-12-31
4 metrics4 newguidance update · 2026-05-14 23:32:33 UTC
2026-05-14 23:32:33 UTC36% – 37%new
2030 Adjusted EBITDA Margin of 36-37%
DXCM · 8-K
2026-05-14 23:31:55 UTCOpen source
2026-05-14 23:32:33 UTC67% – 69%new
2030 Non-GAAP Gross Profit Margin of 67-69%
DXCM · 8-K
2026-05-14 23:31:55 UTCOpen source
2026-05-14 23:32:33 UTC29% – 30%new
2030 Non-GAAP Operating Profit Margin of 29-30%
DXCM · 8-K
2026-05-14 23:31:55 UTCOpen source
2026-05-14 23:32:33 UTCat least 10%new10%
Organic Revenue growth of 10%+ every year through 2030
DXCM · 8-K
2026-05-14 23:31:55 UTCOpen source
DXCMDEXCOM INCFY2026 · ends 2026-12-31
5 metrics5 newearnings call · 2026-05-01 04:01:04 UTC
2026-05-01 04:01:04 UTC50%new
We estimate nearly 50% will be converted by the end of the year over to this new 15-day product.
DXCM · transcript · Q1 FY2026
2026-05-01 04:00:00 UTCOpen source
2026-05-01 04:01:04 UTCcontinue to increasenew
What we'd expect is we do expect R&D spend to continue to increase.
DXCM · transcript · Q1 FY2026
2026-05-01 04:00:00 UTCOpen source
2026-02-13 05:01:16 UTC200 bps – 300 bpsnew200 bps – 300 bps vs FY2025
Our guidance assumes gross margin will improve 200-300 basis points in 2026 as we benefit from lower freight expenses, additional manufacturing efficiencies, and the growing contribution from G7 15-Day.
DXCM · transcript · Q4 FY2025
2026-02-13 05:00:00 UTCOpen source
2026-02-13 05:01:16 UTCoperating margin expansionnew
We also expect that gross margin expansion to play through an operating margin expansion in 2026, even as we have incremental hiring and spending planned to support sales, innovation, and the launch of our Ireland manufacturing facility late in the year.
DXCM · transcript · Q4 FY2025
2026-02-13 05:00:00 UTCOpen source
2026-02-13 05:01:16 UTC1%new1% vs FY2025
In terms of 2026, you know, we had talked about it contributing about a point to growth in 2026, so you guys can do the math on that.
DXCM · transcript · Q4 FY2025
2026-02-13 05:00:00 UTCOpen source
DXCMDEXCOM INCQ1 FY2026 · ends 2026-03-31
1 metric1 newearnings call · 2026-02-13 05:01:16 UTC
2026-02-13 05:01:16 UTC-7% – -6%new
I would say this year we've been talking, and we talked about this at JPMorgan, on stage. We think it's a 6% to 7% decline. So I think the Street's a little bit, it is within the range or probably at the higher end of that range, but not far out of it. It's a pretty safe place to be. So 6%-7% sequential is about what we would think, and there's just a little bit less seasonality this year, than last year.
DXCM · transcript · Q4 FY2025
2026-02-13 05:00:00 UTCOpen source
DXCMDEXCOM INCFY2026 · ends 2026-12-31
1 metric1 newearnings call · 2026-02-13 05:01:16 UTC
2026-02-13 05:01:16 UTCmid-upper teensnew14% – 19% vs FY2025
That mix is still there, but will come down from 2025, that mix impact. So that puts your unit volume growth there just south of that 20%. It puts you in the, you know, the mid-upper teens, and that gives you kind of presumptions around unit volume.
DXCM · transcript · Q4 FY2025
2026-02-13 05:00:00 UTCOpen source
DXCMDEXCOM INCFY2025 · ends 2025-12-31
3 metrics3 maintainedearnings call · 2025-10-31 04:00:45 UTC
2025-10-31 04:00:45 UTC29% – 30%maintained
For both non-GAAP operating margin and adjusted EBITDA margin, we are now guiding to a range of 20%-21% and 29%-30%, respectively, as we expect to offset some of the gross margin pressure through continued OPEX leverage.
DXCM · transcript · Q3 FY2025
2025-10-31 04:00:00 UTCOpen source
2025-10-30 20:03:11 UTC29% – 30%new
Adjusted EBITDA Margin of approximately 29-30%
DXCM · EX-99.1 · Q3 FY2025
2025-10-30 20:02:39 UTCOpen source
2025-10-31 04:00:45 UTC61%maintained
For margins, we are lowering our 2025 non-GAAP gross profit margin guidance to approximately 61% to reflect the additional scrap dynamics we discussed earlier.
DXCM · transcript · Q3 FY2025
2025-10-31 04:00:00 UTCOpen source
2025-10-30 20:03:11 UTC61%new
Non-GAAP Gross Profit Margin of approximately 61%
DXCM · EX-99.1 · Q3 FY2025
2025-10-30 20:02:39 UTCOpen source
2025-10-31 04:00:45 UTC20% – 21%maintained
For both non-GAAP operating margin and adjusted EBITDA margin, we are now guiding to a range of 20%-21% and 29%-30%, respectively, as we expect to offset some of the gross margin pressure through continued OPEX leverage.
DXCM · transcript · Q3 FY2025
2025-10-31 04:00:00 UTCOpen source
2025-10-30 20:03:11 UTC20% – 21%new
Non-GAAP Operating Margin of approximately 20-21%
DXCM · EX-99.1 · Q3 FY2025
2025-10-30 20:02:39 UTCOpen source